First human tests begin for new COPD drug candidate
Knowledge-focused
Completed
This early-stage study tested the safety of a new tablet called Hemay005 in healthy volunteers. Researchers wanted to see if different ways of giving the first doses affected how many side effects people experienced. The goal was to gather basic safety information before testing …
Phase: PHASE1 • Sponsor: Anhui Hemay Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC